Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
All the vital news, analysis, and commentary curated by our industry experts.
Contract Pharmaceutical Dose Manufacturing Industry Overview
The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022.
The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of dose CMO M&A activity, market size, and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
|Value Chain||· API
· Dose Form Manufacturing
|Enquire & Decide||Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.|
Contract Pharmaceutical Dose Manufacturing Industry Trends
The main trends that have affected contract dose trends in the CMO industry in 2022 are classified into business environment factors, high revenue growth environment, and acquisitions shaping the industry.
Inflation remains a major concern for pharma manufacturers as they will most likely be unable to invest as much in innovative capabilities as they did previously due to the current environment of high inflation and quickly rising interest rates, which will increase costs related to transport, energy, and labor. Instead, many manufacturers will refocus on operational efficiency. On the positive side, drug manufacturers will be able to raise their prices, which will increase sales, although government legislation will attempt to curb rising drug prices. Consumers may not react favorably to increasing prices.
Top Contract Dose Trends in the CMO Industry, 2022
Buy the Full Report for More Insights on the CMO Industry Trends, Download a Free Report Sample
Contract Pharmaceutical Dose Manufacturing Industry – Size, Structure, and Growth
This report covers dose CMOs that manufacture a client’s pharmaceutical finished dosage form to supply to the highly regulated markets of the US, Canada, the EU, the UK, and Japan. They actively promote themselves as contract manufacturers and seek contract manufacturing relationships, as evidenced by website and trade show participation.
Buy the Full Report for More Insights into the CMO Industry Forecast
Contract Pharmaceutical Dose Manufacturing Industry - Value Chain
The value chain of the contract manufacturing industry can be simplified into three main segments which are API, dose form manufacturing, and packaging. API is the active component of a drug. In the next layer of the value chain, active and inactive ingredients are combined to produce the final dose form such as a tablet or an injectable.
Packaging can be further segmented into primary packaging and secondary packaging. Primary packaging is the placing of a dose form into a container that makes actual physical contact with the drug, while secondary packaging is the placing of a primary package into an outer container.
Contract Manufacturing Industry Value Chain
Buy Full Report for More Value Chain Insights into the CMO Industry, Download a Free Report Sample
This 63-page report gives an important expert quantitative analysis of the pharmaceutical commercial contract dose manufacturing industry. Findings are based on the industry’s most comprehensive database of the dose CMO industry (GlobalData’s Contract Service Providers Database). This analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 20 figures throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives and strategic decision-makers: to improve understanding of the dose CMO industry and provide critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Private equity investors: they can gain a deeper understanding of the dose CMO market and important insights for identifying potential investment targets.
Reasons to Buy
This report will enable the user to answer the following questions:
- What is the geographic reach of commercial dose CMOs?
- What are revenues did the commercial contract dose manufacturing industry generate in the last year?
- What are the components of revenue change for contract dose manufacturers?
- What is the breakdown of 2022 revenues by different dosage forms?
- What are the characteristics of the largest dose CMOs?
- How did the revenue growth of Contract Dose manufacturers in 2022 compare to Contract API manufacturers?
- What is the outlook for the dose CMO industry?
- What is the outlook for COVID-19 products?
ABCO Laboratories Inc
Acino International AG
Acme Generics LLP
Adnova Healthcare Pvt Ltd
Advanced Accelerator Applications SA
Aenova (Swiss Caps/Dragenopharm)
Agraria Pharma GmbH
Aizant Drug Research Solutions Pvt Ltd
Alfresa Holdings Corp
Ali Raif Ilac Sanayi AS
Allay Pharmaceuticals LLC
Alliance Contract Pharma LLC
Altea Pharmaceutical SA
Althea Technologies Inc.
American Regent/Luitpold Pharmaceuticals
Amol Pharmaceuticals Pvt Ltd
Anfarm Hellas SA
ANI Pharmaceuticals Inc
Annora Pharma Pvt Ltd
Apex Pharmaceuticals Inc
Apotek Produktion & Laboratorier AB
Aquestive Therapeutics Inc
Aristo Pharma GmbH
ASM - Aerosol-Service AG
Aspen Pharmacare Holdings Ltd
Athena Drug Delivery Solutions Pvt Ltd
Athlone Laboratories Ltd
AUPA Biopharm Co Ltd
Australian Pharmaceutical Manufacturer Pty Ltd
Avalon Pharma Pvt Ltd
Bausch & Lomb
BioConnection B. V.
BMP, bulk medicines & pharmaceuticals production gmbh
Boehringer Ingelheim Biopharmaceuticals GmbH
BOLDER Arzneimittel GmbH
BSP Pharmaceuticals SpA
Bymaa Laboratories Pvt Ltd
Caleb Pharmaceuticals Inc
Capsula Operculata GmbH
Cederroth Paramedical AS
Choseido Pharmaceutical Co Ltd
Citra Pharma Manufacturing
CMIC Holdings Co Ltd
Colep Portugal SA
Confab Laboratories Inc
Contract Coating Inc
Contract Manufacturing and Packaging Services Pty Ltd
Contract Pharmaceuticals Ltd
Daewoo Pharmaceutical Co Ltd
Daito Pharmaceutical Co Ltd
Debiopharm Research & Manufacturing SA
Dechra Pharmaceuticals Plc
Doppel Farmaceutici Srl
Douglas Pharmaceuticals Ltd
Dr. R. Pfleger
Emergent BioSolutions Inc
Eurofins Scientific SE
European Medical Contract Manufacturing BV
Ever Pharma GmbH
Evertogen Lifesciences Ltd
Evonik Industries AG
Exela Pharma Sciences
Faes Farma SA
Farmaceutici Procemsa SpA
Farmaceutisch Analytisch Laboratorium Duiven BV
Farmalabor (Grupo medinfar)
Fine Foods NTM Spa
First Time US Generics LLC
Formosa Laboratories Inc
Formulation Technology Inc
Francia Farmaceutici Industria Farmaco Biologica Srl
Fuji Pharma Co Ltd
G&W Laboratories, Inc.
Glatt Pharmaceutical Services
Grand River Aseptic Manufacturing
Granulation Technology Inc
Guardian Drug Company
Hainan Visum Pharmaceutical Co Ltd
Hangzhou Minsheng Pharmaceutical Group Co Ltd
Health Pharma USA LLC
Hercon Pharmaceuticals LLC
Holopack Verpackungstechnik GmbH
Huayi Pharmaceutical (Anhui) Co Ltd
Hudson Scientific LLC
IDT Australia Ltd
Incepta Pharmaceuticals Ltd
Indeus Life Sciences Private Limited
Inva-Tech Pharma Solutions LLC
IPC Process-Center GmbH & Co KG
JAMP Pharma Corp
Jiangsu Wanbang Biochemical Pharmaceutical Group Co Ltd
Jilin Qijian Bio Pharmaceutical Co Ltd
Jodas Expoim Pvt Ltd
JOINN Biologics Inc
JONAKAYEM Pharma-Formulation (OPC) Pvt Ltd
Kemwell Biopharma Pvt Ltd
Kindeva Drug Delivery LP
Kleva Pharmaceuticals SA
Klocke Pharma-Service GmbH
Laboratoire Riva Inc
Laboratoires Chemineau SAS
Laboratoires Galéniques Vernin (LGV)
Laboratoires Lavoiser Chaix
Laboratoires Pierre Fabre SA
Laboratorio Farmaceutico CT
Laboratorios Farmaceuticos Rovi SA
Laboratorios Normon SA
Laleham Health And Beauty Ltd
Lamp San Prospero SPA
Lannett Co Inc
Lecifarma - Pharmaceutical Laboratory Ltd
Lifecore Biomedical LLC
Lomapharm - Rudolf Lohmann GmbH
Lotus Pharmaceutical Co Ltd
Lozys Pharmaceuticals SL
LTS Lohmann Therapie-Systeme GmbH
Lyrus Life Science Pvt Ltd
Mahavir Laboratories Pvt Ltd
Marifarm proizvodnja in storitve d o o
Medical Products Laboratories Inc
Merck & Co Inc
MIAS Pharma Ltd
Milan Laboratories (India) Pvt Ltd
Morepen Laboratories Ltd
Murli Krishna Pharma Pvt. Ltd.
Nephron Pharmaceuticals Corporation
NextPharma Technologies Holding Ltd
Niche Generics Ltd
Nordmark Arzneimittel GmbH & Co. KG
Nostrum Laboratories LLC
Novast Holdings Ltd
Olds Softgels Inc
Oncomed Manufacturing a.s
Orient Pharma Co Ltd
Orofino Pharmaceuticals Group
PCI Pharma Services
Pernix Pharma Pharmaceutical Manufacturing Ltd
Perrigo Co Plc
Pharbest Pharmaceuticals Inc
Pharma Stulln GmbH
Pharma Tech Industries
Pharmaceutics International Inc
Piramal Pharma Solutions
Pure Origin Group
Purzer Pharmaceutical Co Ltd
Qilu Antibiotics Pharmaceutical Co Ltd
Qualigens Pharma Pvt Ltd
Quantum Pharmaceutical Ltd
Raritan Pharmaceuticals Inc
Rechon Life Science
RubiePharm Arzneimittel GmbH
S. Zhaveri Pharmakem Pvt Ltd
SAG Manufacturing SLU
Salubrent Pharma Solutions
SENSILAB Polska Sp zoo SKA
Siegfried Holding AG
Societal CDMO Inc
Softech Pharma Pvt Ltd
Statens Serum Institut
Sterling Pharmaceutical Services
Sterling Pharmaceuticals Ltd
Sunny Pharmtech Inc
Suraksha Pharma Pvt Ltd
Symbiosis Pharmaceutical Services
Sypharma Pty Ltd
Taiyo Pharma Tech Co Ltd
Tarsal Pharmaceuticals Inc
Tesa Labtec GmbH
The Ritedose Corp
Thepenier Pharma Industrie S.A.
Titan Laboratories Pvt Ltd
Toa Pharmaceuticals Co Ltd
Torrent Pharmaceuticals Ltd
Towa Pharmaceutical Co Ltd
Tower Laboratories, Ltd
Trillium Health Care Products Inc.
Tripak Pharmaceuticals Pty Ltd
Trividia Manufacturing Solutions Inc
Tulex Pharmaceuticals Inc
TWi Pharmaceuticals Inc
UBI Pharma Inc
Valcon Medical AS
Vinkem Pharma LLC
Vistin Pharma AS
VKT Pharma Pvt Ltd
Vovantis Laboratories Pvt Ltd
Wagener & Co. GmbH
Winder Laboratories LLC
Woodfield Pharmaceutical LLC
Yooyoung Pharmaceutical Co Ltd
Zhejiang Bamboo Pharmaceuticals Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd
Table of Contents
- 1 Executive Summary
- 2 Players
- 3 Trends
- 4 Industry Size and Structure
- 4.1 Definition of the dose CMO universe
- 4.2 Industry demographics
- 4.2.1 Global versus regional reach
- 4.2.2 Dosage forms
- 4.3 Major developments affecting industry structure
- 4.3.1 Dose facility acquisitions
- 4.3.2 Dose company acquisitions
- 4.3.3 PE acquisitions
- 5 Industry Size and Growth
- 5.1 Dose manufacturing
- 5.1.1 Inflation
- 5.1.2 Components of growth
- 5.1.3 Revenue by dosage form
- 5.1 Dose manufacturing
- 6 CMO Market Shares
- 6.1 Characteristics of the largest CMOs
- 7 COVID-19 Products Sales Forecast
- 8 Analyzing Recent Dose CMO Industry Performance
- 8.1 COVID-19 influence
- 8.2 High inflation effect
- 8.3 Service-specific growth
- 8.4 Cell and gene therapy investment
- 8.5 Sponsor-CMO relationships
- 9 What It Means
- 10 Value Chain
- 11 Companies
- 12 Appendix
- 12.1 Methodology
- 12.1.1 Methodology for market size and growth estimates
- 12.1.2 Deals years
- 12.1.3 CMO classifications
- 12.2 Bibliography
- 12.3 Primary research – key opinion leaders
- 12.4 Further reading
- 12.1 Methodology
- 13 About the Authors
- 14 Contact Us
Frequently asked questions
What are the value chains of the contract manufacturing industry?
The value chain of the contract manufacturing industry can be simplified into three main segments which are API, dose form manufacturing, and packaging.
Which is the most active value chain component of the contract manufacturing industry?
API is the most active value chain component of the contract manufacturing industry.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.